サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414327

ニューロモデュレーション体内デバイスの世界市場レポート 2024年

Internal Neuromodulation Devices Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニューロモデュレーション体内デバイスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ニューロモデュレーション体内デバイスの市場規模は近年力強く成長しています。2023年の24億7,000万米ドルから2024年には26億6,000万米ドルへと、CAGR7.7％で拡大します。この期間の拡大は、慢性疼痛の管理、高齢化、臨床研究や臨床試験への注目の高まり、神経疾患の有病率、患者の意識とKEYWORDの受容の高まりなどの要因によるものです。

ニューロモデュレーション体内デバイス市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.9％で36億1,000万米ドルに成長します。予測期間中に予想される成長は、個別化医療の動向、ヘルスケア支出の増加、業界内の提携やパートナーシップ、患者の転帰と実世界のエビデンスへの注目、規制状況の変化などに起因しています。予測期間に予想される主な動向には、小型化と埋め込み技術の発展、無線接続と遠隔モニタリングの統合、ニューロモデュレーションの用途拡大、正確な調節のための閉ループシステムの開発、患者中心の設計への注目の高まりなどが含まれます。

神経系疾患の有病率の増加が予想されることから、ニューロモデュレーション体内デバイス市場は当分の間、成長が見込まれます。神経系疾患には、脳、脊髄、末梢神経を含む神経系に影響を及ぼす幅広い疾患が含まれます。ニューロモデュレーション体内デバイスは、神経系の特定部位に電気刺激を与え、慢性疼痛、運動障害、気分障害などの症状を緩和することで、神経疾患や精神疾患の治療に重要な役割を果たしています。これらの機器は、症状を緩和し、日常生活を円滑にすることで、患者のQOL向上に貢献しています。例えば、2021年に米国疾病予防管理センターが発表したところによると、アルツハイマー病は65歳以上の米国人約620万人が罹患しており、この数は2060年までに約3倍の1,400万人になると予想されています。さらに、65歳以降は5年ごとに発症率が倍増します。このように、神経疾患の有病率の増加は、ニューロモデュレーション体内デバイス市場の成長の原動力となっています。

脳腫瘍の罹患率の上昇は、ニューロモデュレーション体内デバイス市場の拡大に拍車をかけると予測されています。脳や脊髄に発生する多様な腫瘍群である脳腫瘍は、理解や治療に複雑な課題をもたらします。ニューロモデュレーション体内デバイスは、さまざまな脳疾患に対する有望な治療ソリューションとして登場し、電気刺激やその他の形態のエネルギーを脳の特定部位に直接送り込むことで、神経細胞の活動を調節し、治療効果を誘発します。2022年、全米脳腫瘍学会は、約94,390人の米国人が脳腫瘍と診断され、2023年には18,990人が悪性脳腫瘍で死亡すると推定されると報告しています。このように、脳腫瘍の発生率の増加は、ニューロモデュレーション体内デバイス市場の成長の触媒として機能しています。

2023年のニューロモデュレーション体内デバイス市場で最大の地域は北米でした。アジア太平洋は、ニューロモデュレーション体内デバイスの世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。ニューロモデュレーション体内デバイス市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のニューロモデュレーション体内デバイス市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 脊髄刺激装置
  • 深部脳刺激装置
  • 仙骨神経刺激装置
  • 迷走神経刺激装置
  • 胃神経刺激装置
  • 世界のニューロモデュレーション体内デバイス市場、技術タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 体内ニューロモデュレーション
  • 体外ニューロモデュレーション
  • 世界のニューロモデュレーション体内デバイス市場、生体材料別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 金属生体材料
  • 高分子生体材料
  • セラミック生体材料
  • 世界のニューロモデュレーション体内デバイス市場、用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腰部手術失敗症候群
  • パーキンソン病
  • 尿失禁
  • てんかん
  • 胃不全麻痺
  • 世界のニューロモデュレーション体内デバイス市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • 在宅ヘルスケア
  • 地域ヘルスケア

第7章 地域および国の分析

  • 世界のニューロモデュレーション体内デバイス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のニューロモデュレーション体内デバイス市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ニューロモデュレーション体内デバイス市場の競合情勢
  • ニューロモデュレーション体内デバイス市場の企業プロファイル
    • Medtronic plc
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • BioControl Medical Ltd.
    • Aleva Neurotherapeutics SA

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11837

“Internal Neuromodulation Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on internal neuromodulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for internal neuromodulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The internal neuromodulation devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
  • 2) By Technology Type: Internal Neuromodulation; External Neuromodulation
  • 3) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
  • 4) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
  • 5) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Cyberonics Inc.; BioControl Medical Ltd.; Aleva Neurotherapeutics SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.

The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.

The internal neuromodulation devices market research report is one of a series of new reports from The Business Research Company that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The expansion observed in the historical period can be attributed to factors such as the management of chronic pain, the aging population, increased focus on clinical research and trials, the prevalence of neurological disorders, and growing patient awareness and acceptance of internal neuromodulation devices.

The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to trends in personalized medicine, increasing healthcare expenditure, collaborations and partnerships within the industry, a focus on patient outcomes and real-world evidence, and changes in the regulatory landscape. Key trends expected in the forecast period encompass advancements in miniaturization and implantable technology, the integration of wireless connectivity and remote monitoring, expanded applications for neuromodulation, the development of closed-loop systems for precise modulation, and a heightened focus on patient-centric design.

The anticipated increase in the prevalence of neurologic diseases is poised to drive the growth of the internal neuromodulation devices market in the foreseeable future. Neurologic diseases encompass a wide range of disorders affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices play a crucial role in treating neurological and psychiatric conditions by administering electrical stimulation to specific areas of the nervous system, offering relief from symptoms such as chronic pain, movement disorders, and mood disorders. These devices contribute to enhancing patients' quality of life by alleviating symptoms and facilitating daily activities. For example, in 2021, the Centers for Disease Control and Prevention reported that Alzheimer's disease affected approximately 6.2 million Americans aged 65 and older, a number expected to nearly triple to 14 million by 2060. Additionally, the incidence of the disease doubles every five years after the age of 65. Thus, the increasing prevalence of neurologic diseases is a driving force behind the growth of the internal neuromodulation devices market.

The rising incidence of brain cancers is anticipated to fuel the expansion of the internal neuromodulation devices market. Brain cancer, a diverse group of tumors originating in the brain or spinal cord, poses complex challenges for understanding and treatment. Internal neuromodulation devices emerge as a promising therapeutic solution for various brain disorders, delivering electrical stimulation or other forms of energy directly to specific brain regions to modulate neuronal activity and induce therapeutic effects. In 2022, the National Brain Tumor Society reported an expected diagnosis of brain tumors in approximately 94,390 Americans, with an estimated 18,990 deaths from malignant brain tumors in 2023. Thus, the growing incidence of brain cancers serves as a catalyst for the growth of the internal neuromodulation devices market.

A prominent trend gaining traction in the internal neuromodulation devices market is product innovation. Major companies in this segment are actively engaged in developing new technologies to maintain their market positions. For instance, in March 2023, Ireland-based medical equipment manufacturer Neuromod Device Ltd. announced that its Lenire system had received De Novo clearance from the US Food and Drug Administration (FDA). The Lenire system employs a combination of sound stimulation and tongue stimulation to treat tinnitus, a neurological disorder characterized by ringing in the ears. This innovative system uses a dual-pronged approach to neurostimulation, utilizing Bluetooth headphones to play unique sounds stimulating the auditory nerve, while Neuromod's Tonguetip device transmits moderate electrical stimulation to the tongue's surface. This technology provides otolaryngologists with an innovative tool to recommend to patients experiencing a moderately negative impact on their lives due to tinnitus.

Major companies in the internal neuromodulation devices market are concentrating on developing technological innovations, including digital health apps, to gain a competitive edge. Digital health apps are software applications designed to deliver health-related services and information to users on mobile devices. For example, in July 2022, US-based medical device provider Abbott Laboratories launched the NeuroSphere Virtual Clinic, a groundbreaking technology allowing patients with Abbott's neurostimulation devices to remotely communicate with doctors. This feature enables patients to ensure proper settings, functionality, and receive new treatment settings via secure in-app video chat and integrated remote programming. The platform provides real-time data to physicians about patients' device usage and pain levels.

In March 2022, US-based medical equipment manufacturer Electromedical Products International (EPI) acquired Pulvinar Neuro for an undisclosed amount. Through this acquisition, Pulvinar Neuro gains enhanced capabilities for promoting its patented technologies, such as transcranial alternating current stimulation (tACS). Additionally, the acquisition enhances its cloud-enabled digital treatments for mental and neurological conditions and customized feedback stimulation. Pulvinar Neuro is a US-based medical technology company specializing in deep brain stimulation (DBS) systems for treating neurological and psychiatric disorders.

Major companies operating in the internal neuromodulation devices market report are Medtronic plc, Boston Scientific Corporation, Cyberonics Inc., BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, St. Jude Medical Inc., EnteroMedics Inc., Micron Medical Corporation, LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Accellent Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

North America was the largest region in the internal neuromodulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Internal Neuromodulation Devices Market Characteristics

3. Internal Neuromodulation Devices Market Trends And Strategies

4. Internal Neuromodulation Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Internal Neuromodulation Devices Market Size and Growth

  • 5.1. Global Internal Neuromodulation Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Internal Neuromodulation Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Internal Neuromodulation Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Internal Neuromodulation Devices Market Segmentation

  • 6.1. Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Neuro Stimulator
  • 6.2. Global Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation
  • 6.3. Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • 6.4. Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Failed Back Surgery Syndrome
  • Parkinson's Disease
  • Urinary Incontinence
  • Epilepsy
  • Gastroparesis
  • 6.5. Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare
  • Community Healthcare

7. Internal Neuromodulation Devices Market Regional And Country Analysis

  • 7.1. Global Internal Neuromodulation Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Internal Neuromodulation Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Internal Neuromodulation Devices Market

  • 8.1. Asia-Pacific Internal Neuromodulation Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Internal Neuromodulation Devices Market

  • 9.1. China Internal Neuromodulation Devices Market Overview
  • 9.2. China Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Internal Neuromodulation Devices Market

  • 10.1. India Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Internal Neuromodulation Devices Market

  • 11.1. Japan Internal Neuromodulation Devices Market Overview
  • 11.2. Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Internal Neuromodulation Devices Market

  • 12.1. Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Internal Neuromodulation Devices Market

  • 13.1. Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Internal Neuromodulation Devices Market

  • 14.1. South Korea Internal Neuromodulation Devices Market Overview
  • 14.2. South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Internal Neuromodulation Devices Market

  • 15.1. Western Europe Internal Neuromodulation Devices Market Overview
  • 15.2. Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Internal Neuromodulation Devices Market

  • 16.1. UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Internal Neuromodulation Devices Market

  • 17.1. Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Internal Neuromodulation Devices Market

  • 18.1. France Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Internal Neuromodulation Devices Market

  • 19.1. Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Internal Neuromodulation Devices Market

  • 20.1. Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Internal Neuromodulation Devices Market

  • 21.1. Eastern Europe Internal Neuromodulation Devices Market Overview
  • 21.2. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Internal Neuromodulation Devices Market

  • 22.1. Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Internal Neuromodulation Devices Market

  • 23.1. North America Internal Neuromodulation Devices Market Overview
  • 23.2. North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Internal Neuromodulation Devices Market

  • 24.1. USA Internal Neuromodulation Devices Market Overview
  • 24.2. USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Internal Neuromodulation Devices Market

  • 25.1. Canada Internal Neuromodulation Devices Market Overview
  • 25.2. Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Internal Neuromodulation Devices Market

  • 26.1. South America Internal Neuromodulation Devices Market Overview
  • 26.2. South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Internal Neuromodulation Devices Market

  • 27.1. Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Internal Neuromodulation Devices Market

  • 28.1. Middle East Internal Neuromodulation Devices Market Overview
  • 28.2. Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Internal Neuromodulation Devices Market

  • 29.1. Africa Internal Neuromodulation Devices Market Overview
  • 29.2. Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Internal Neuromodulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Internal Neuromodulation Devices Market Competitive Landscape
  • 30.2. Internal Neuromodulation Devices Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Boston Scientific Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cyberonics Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. BioControl Medical Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Aleva Neurotherapeutics SA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Internal Neuromodulation Devices Market Competitive Benchmarking

32. Global Internal Neuromodulation Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Internal Neuromodulation Devices Market

34. Internal Neuromodulation Devices Market Future Outlook and Potential Analysis

  • 34.1 Internal Neuromodulation Devices Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Internal Neuromodulation Devices Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Internal Neuromodulation Devices Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer